Learn more about CERo's vision: #CancerResearch #Immunotherapy #ClinicalTrials To view or add a comment, sign in The TORPEDO trial dropped at ASTRO
To maximize efficacy while minimizing side effects, a common dose escalation regimen in metabolic studies is as follows: Weeks 14: 2 mg weekly (to reduce gastrointestinal side effects) Weeks 58: 4 mg weekly Weeks 912: 8 mg weekly Week 13 onward: 12 mg weekly for optimal results Beyond these metabolic effects, retatrutide is paving the way for exciting advances in tissue repair research
Digestive side effects like vomiting or diarrhea can pull magnesium and potassium lower, and there is some evidence these medications can reduce iron levels
It started as a small group of friends sharing progress and support
At 40 weeks, participants taking 15 mg weekly of tirzepatide (the maximum dose of Mounjaro and Zepbound) lost 11.2% of their body weight
AOD 9604 + NAD+ Combining AOD 9604 with NAD+ therapy at Perfect B in Doral targets two separate axes of metabolic function: NAD+ addresses cellular energy metabolism, mitochondrial efficiency, and metabolic resilience at the enzymatic level, while AOD 9604 drives fat mobilization from adipose tissue
